Alzheimer’s disease tagged posts

‘Housekeepers’ of the Brain Renew themselves more quickly than first thought

Microglia cells (green spider shapes). Credit: Image courtesy of University of Southampton

Microglia cells (green spider shapes). Credit: Image courtesy of University of Southampton

Cells in the brain responsible for detecting and fixing minor damage renew themselves more quickly than previously thought, new research has shown. A study, led by the University of Southampton shows that the turnover of Microglia, is 10X faster, allowing the whole population of Microglia cells to be renewed several times during a lifetime.

“Microglia are constantly scanning the brain to find and fix issues — you could call them the housekeepers of the brain,” said Dr Diego Gomez-Nicola, of the University of Southampton, who supervised the study. “We previously thought that microglia would renew themselves so slowly that a whole lifetime would not suffice to renew the whole population...

Read More

Promising Discovery for a Non-Invasive Early Detection of Alzheimer’s disease

High molecular weight tau bands (about 80kDa) can be appreciated, with greater immunoreactivity in patients with AD compared with healthy subjects. Credit: Dr. Ricardo B. Maccioni

High molecular weight tau bands (about 80kDa) can be appreciated, with greater immunoreactivity in patients with AD compared with healthy subjects. Credit: Dr. Ricardo B. Maccioni

Drs Maccioni and Farías have pioneered the technology that detects in human blood platelets the pathological oligomeric forms of brain tau protein in patients with Alzheimer’s disease (AD) and other neurodegenerative disorders. More importantly, the ratio between this anomalous tau and the normal tau protein can discriminate AD patients from normal controls, and are associated with decreased cognitive impairment. These studies open a new avenue in the development of highly sensitive and efficient biomarkers for neurodegenerative disorders...

Read More

Glaucoma Drug may have potential to treat Alzheimer’s disease

Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

α2A agonists directly affect the non-amyloidogenic pathway and are neuroprotective through sAPPα.

In trials on rats, the drug brimonidine, which is routinely used to lower eye pressure in glaucoma patients, has been found to reduce the formation of amyloid proteins in the retina, which are believed to be linked to Alzheimer’s. The research was reported in the journal Cell Death and Disease. Amyloid plaques can be seen in the retinas of people with Alzheimer’s, so the researchers say the retina can be viewed as an extension of the brain that provides an opportunity to diagnose and track progression of Alzheimer’s.

Scientists found that brimonidine reduces neurodegeneration of cells in the retina by cutting the levels of beta amyloid in the eye...

Read More

New Insight into How Alzheimer’s disease Begins

Tau aggregation in disease

Tau aggregation in disease

A relationship between inflammation, a toxic protein and the onset of the disease has been found. The study also identified a way that doctors can detect early signs of Alzheimer’s by looking at the back of patients’ eyes. “Early detection of Alzheimer’s warning signs would allow for early intervention and prevention of neurodegeneration before major brain cell loss and cognitive decline occurs,” said Ashley Nilson, a neuroscience graduate student. “Using the retina for detecting AD and other neurodegenerative diseases would be non-invasive, inexpensive and could become a part of a normal screening done at patient checkups.”

UTMB researchers have previously found evidence that a toxic form of tau protein may underlie the early stages of Alzheimer’s...

Read More